Fact CheckerSign in

NCT02471352Recruiting

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Brief summary (registry, in English)

Background: \- Skin disease can have many causes. It can have widespread consequences, and in rare cases can lead to death. Researchers want to determine the causes of various types of skin diseases and find a way to treat them. Objectives: \- To determine the causes of various skin diseases and find ways to treat them. Eligibility: * People ages 2 and older who have: * A skin disease or at risk of developing a skin disease OR * A family member of persons with a skin disease * Healthy volunteers ages 2 and older Design: * Participants will be screened under a separate protocol. * Participants may take a survey about how their skin condition affects their quality of life. * Participants will have a medical history and a physical exam including a detailed skin exam. Pictures will be taken of their skin to document any skin disease. * Participants will have specimens collected. This may include: * Several teaspoons of blood taken at each visit * Stool samples * Nail and body fluid (like saliva) samples * Cheek swabs. The inside of the cheek will be scraped for about a minute in each direction to collect cells. * Collection of skin samples with: * A swab (like a Q-tip) * Gently scraping skin to remove the outer layers of cells * Applying and removing 1-inch pieces of tape * Participants may have up to 4 skin biopsies in 12 months, with 4 separate biopsies taken each time. * An area of skin will be numbed with an injection. * A piece of skin the size of a pencil eraser will be removed using a small instrument. * A flat scar usually develops at the biopsy site.

Status (registry)
Recruiting
Study type
Observational
Enrollment
700 (estimated)
First submitted
12 Jun 2015
Start date
19 Jun 2015
Primary completion date
31 Jan 2035
Lead sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT number
NCT02471352

What you commit to

  • Study type: Observational
  • Planned participants: 700
  • From 19 Jun 2015 to the primary completion date, 31 Jan 2035
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of conditions that, in the judgment of the investigator, may put the subject at undue risk or make them unsuitable for participation in the study.

Other

  • Inability to comply with the requirements of the protocol.

Criteria the registry did not label

  • INCLUSION CRITERIA:
  • Eligible participants must:
    • Have a dermatologic condition, as determined by the PI or AIs, OR --be at risk for developing a dermatologic condition, as determined by the PI or AIs, OR
    • be a family member of a person with a dermatologic condition OR
    • be a healthy volunteer, as defined as a person with no known significant health problems.
    • Be willing to provide biospecimens for research and clinical studies, and for storage to be used for future research.
    • Subjects of age greater than 0 years old (including only viable neonates) are eligible.

Age in the registry: 1 day to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Institutes of Health Clinical Center
Coordinator of this site? Confirm its status
BethesdaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.